Zdrowie i gospodarka · 13/07/2020
FDA Finalizes Withdrawal of Approval for Pentaerythritol Tetranitrate
The US Food and Drug Administration (FDA) has confirmed its decision to withdraw approval for pentaerythritol tetranitrate (PETN) for treating angina pectoris, following the withdrawal of exceptions to the initial decision by all parties involved.
Source: Federal Register — Food and Drug AdministrationOpen original release →